99(ii) Press Release re: termination of proposed merger between the
            Company and MainStreet IPO.com Inc. dated August 21, 2000.



                             Press Release

          PROPOSED MERGER WITH MAINSTREET IPO.COM INC. IS CANCELLED

Lemoyne, Pennsylvania, August 21, 2000 - Dialysis Corporation of America
("DCA") (Nasdaq SmallCap Market - DCAI) announces that its proposed merger
with MainStreet IPO.com Inc. is terminated.  The parties signed a Merger
Agreement in October, 1999, and MainStreet filed a registration statement
in February, 2000, which included DCA's proxy statement intended for the
solicitation of its minority public shareholders relating to the proposed
merger and ancillary proposed sale by DCA of substantially all of its assets
to its parent, Medicore, Inc.  The SEC provided extensive comments to
MainStreet's registration statement, including certain regulatory issues.
The Merger Agreement contemplated an effective MainStreet registration
statement, the solicitation of DCA's minority public shareholders and their
approval of the proposed merger with MainStreet and related sale of DCA
assets to Medicore, all of which was to occur on or before May 31, 2000.
The Agreement also contemplated satisfaction of a variety of conditions,
which included, among others, no material change in MainStreet's proposed
operations, receipt of consents and approvals of governmental authorities,
and MainStreet satisfying Nasdaq listing requirements.  Although the Company
has exhibited patience as to the merger conditions, deadlines, and
MainStreet's attempts at resolving the concerns of the SEC, the failure of
these conditions and MainStreet's efforts has resulted in the termination of
the proposed merger.

DCA owns and operates free-standing kidney hemodialysis centers in Pennsyl-
vania and New Jersey, with planned expansion into other states.  Currently,
two new dialysis facilities are under construction in Georgia and Ohio, with
two additional dialysis centers in the planning stage to provide patients
with their choice of a full range of quality in-center, acute, or at-home
hemodialysis services.  DCA has entered into two additional in-patient
hospital dialysis services agreements, has expanded its patient base, and
continues its negotiations with other physicians and hospitals for further
development.

This release contains forward-looking statements that are subject to risks
and uncertainties, including but not limited to, certain delays beyond the
Company's control with respect to future business events, regulation of
dialysis operations, government rate determination for Medicare reimburse-
ment, the highly competitive environment in the operation and acquisition
of dialysis centers, the ability to develop additional dialysis facilities,
whether patient bases of our facilities can expand to provide profitability
and other risks detailed from time to time in the Company's filings with
the Securities and Exchange Commission.

CONTACT:  For more information, contact Thomas K. Langbein, CEO, Dialysis
Corporation of America, 777 Terrace Avenue, Hasbrouck Heights, New Jersey
07604.  Telephone No. (210) 288-8222.